Aclaris Therapeutics Earnings Estimate

ACRS Stock

USD 3.82 0.19 5.23%

By analyzing Aclaris Therapeutics' earnings estimates, investors can diagnose different trends across Aclaris Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Aclaris Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.

Yuan Drop

Covid

Aclaris Therapeutics is projected to generate -0.192075 in earnings per share on the 31st of December 2024. Aclaris Therapeutics earnings estimates module stress-tests analyst consensus about projected Aclaris Therapeutics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Aclaris Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Aclaris Therapeutics Revenue Breakdown by Earning Segment

By analyzing Aclaris Therapeutics' earnings estimates, investors can diagnose different trends across Aclaris Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 13.8 M in 2024, whereas Pretax Profit Margin is likely to drop (2.99) in 2024.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Aclaris Therapeutics Earnings per Share Projection vs Actual

About Aclaris Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Aclaris Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Aclaris Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Aclaris Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	-770.8 M	-732.3 M
Retained Earnings Total Equity	-614.1 M	-583.4 M
Earnings Yield	(1.21)	(1.15)
Price Earnings Ratio	(0.83)	(0.87)
Price Earnings To Growth Ratio	0.13	0.13

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aclaris Stock Analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC